Last reviewed · How we verify
NCT05132309
Intestinal Microbiota Composition in Patients With Chronic Pancreatitis and Pancreatic Exocrine Insufficiency
trial testing enzyme replacement therapy in Chronic Pancreatitis in 96 participants. Completed in 1 July 2021.
1 July 2021
Quick facts
| Lead sponsor | Federal Research and Clinical Center of Physical-Chemical Medicine |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 96 |
| Start date | 1 November 2020 |
| Primary completion | 1 July 2021 |
| Estimated completion | 1 July 2021 |
| Sites | 2 locations across Russia |
Drugs / interventions tested
- enzyme replacement therapy — full drug profile →
Conditions studied
- Chronic Pancreatitis — all drugs for Chronic Pancreatitis →
- Pancreatic Exocrine Insufficiency — all drugs for Pancreatic Exocrine Insufficiency →
Sponsor
Federal Research and Clinical Center of Physical-Chemical Medicine
Who can join
Adults 23 to 80, any sex, with Chronic Pancreatitis or Pancreatic Exocrine Insufficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Assessment of qualitative and quantitative composition of the intestinal microbiota in patients with CP; in patients with CP and PEI complication of mild to severe degree; patients with CP and PEI who underwent surgical intervention on the pancreas. Intergroup comparison of the microbial compositional characteristics and their analysis. Correction of enzyme replacement therapy in selected groups of patients with regard to the identified microbial characteristics. Assessment of the intestinal microbiota composition in dynamics after 6 (+1) months on the background of allocated therapy
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05132309
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Pancreatitis
Currently open trials in the same condition.
- NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting
- NCT06655051 — Single Plastic Stent Vs. Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancr · NA · recruiting
- NCT06937294 — Metformin in Post Chronic Pancreatitis Diabetes Mellitus · Phase 4 · recruiting
- NCT07109180 — Robot-assisted Versus Open Lateral Pancreaticojejunostomy for the Treatment of Symptomatic Chronic Pancreatitis (PANACOT · NA · recruiting
- NCT06925204 — Natural Course and Therapeutic Effect of Chronic Pancreatitis · recruiting
Other Federal Research and Clinical Center of Physical-Chemical Medicine trials
Trials by the same sponsor.
- NCT04579263 — Assessment of the Health Improvement of Obese Patients After Fecal Microbiota Transplantation (FMT) · NA · completed
- NCT04011943 — Fecal Microbiota Transplantation for Health Improvement (TFM3) · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05132309 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federal Research and Clinical Center of Physical-Chemical Medicine
- Last refreshed: 24 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05132309.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing